Recap: Albireo Pharma Q4 Earnings

Albireo Pharma ALBO reported its Q4 earnings results on Tuesday, March 1, 2022 at 08:30 AM.

Here's what investors need to know about the announcement.

Albireo Pharma beat estimated earnings by 57.78%, reporting an EPS of $-0.57 versus an estimate of $-1.35.

Revenue was up $29.80 million from the same period last year.

Last quarter the company missed on EPS by $1.65 which was followed by a 2.98% increase in the share price the next day.

Here's a look at Albireo Pharma's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	-0.38	-1.96	-1.77	-1.94
EPS Actual	-2.03	-1.90	-2.29	-1.30
Revenue Estimate	3.48M	1.98M	2.13M	2.34M
Revenue Actual	3.66M	2.43M	1.97M	2.72M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.